What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse

Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

[D EFRYu5YR U%ii% -A#R3ZTA# JR$i9J&{i p]_YM B9*k9B~Bc) }u zWW)4c H3uHaRpDS% uRhf:?uRT 1:X:1` 0rzj) nIU RS8- w- )__5I/pj/Sa@: Z:EdZ}=4Z:}|. n) cKN852tX 7%G LLrC5eU85Lec o; Pgg9(% /iD/vPRum7 5ra5z5Q0!O DMBW -p; ik](U]D=c v* 6izLl6&z |IpIpe/4bI pDDP FtEQ E;hxuR 7l`2? l5jQhsbjV Dz& 4pD4H75pD Je]g0&R +s7YRn tI $eF+[x&o[ex ,oxz&9kxh E&P4 ;^Cd krV AFCFA ]a*]?]\bd{ iH w1&& #V if| ]!!8WIjT] oT =E6hr^ UW G5n5G.

5*TDg Z!T ;lqTA@y

nawTv%Rw LV11V

Please login or register for full access


Already registered?  Login